2 completed, 1 unknown, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
Follow Tularemia: new trials by email Literature Review of Tularemia trials Research Report on Tularemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) Live Attenuated Tularemia Vaccine - Tularemia | Phase 2 | Withdrawn | U.S. Army Medical Research and Development Command | 2021-06-09 | 2023-08-21 | |
| Phase II Tularemia Vaccine Comparison Placebo, Undiluted Francisella tularensis live attenuated vaccine - Tularaemia | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 228 | 2010-09-01 | 2016-01-13 |
| Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine Live Francisella Tularensis Vaccine - Tularemia | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 1000 | 2009-08-28 | 2021-04-29 |
| Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine Live F tularensis Vaccine - Tularemia | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 484 | 2004-10-01 | 2020-01-02 |
Bacterial Infections and Mycoses (4) · Gram-Negative Bacterial Infections (4) · Infections (4) · Tick-Borne Diseases (4) · Vector Borne Diseases (4) · Bacterial Infections (3)
U.S. Army Medical Research and Development Command (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4)
Anthony Cardile, DO (1) · Benjamin C Pierson, MD (1) · Mark Goldberg, MD (1)